SAN DIEGO, Oct. 03, 2025 ( GLOBE NEWSWIRE ) -- Johnson Fistel, PLLP is investigating potential legal claims on behalf of Capricor Therapeutics, Inc. ( NASDAQ:CAPR ) shareholders, concerning alleged misconduct by certain officers and directors that may have harmed the company and its investors.

Capricor治療

<p>聖地亞哥，2025 年 10 月 3 日（GLOBE NEWSWIRE）-- Johnson Fistel, PLLP 正在調查代表 Capricor Therapeutics, Inc.（納斯達克：CAPR）股東的潛在法律索賠，涉及某些高管和董事的涉嫌不當行為，這可能對公司及其投資者造成了損害</p>

Capricor Therapeutics, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation

Capricor 治療公司長期股東公告：Johnson Fistel 鼓勵投資者聯繫以獲取更多關於持續調查的信息